Second malignancies in patients with neuroblastoma: The effects of risk-based therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Second malignancies in patients with neuroblastoma: The effects of risk-based therapy

Published:2014-09-23 Issue:1 Volume:62 Page:128-133
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Applebaum Mark A.¹,Henderson Tara O.¹,Lee Sang Mee²,Pinto Navin¹³^ORCID,Volchenboum Samuel L.¹⁴⁵,Cohn Susan L.¹³

Affiliation:

1. Departments of Pediatrics; University of Chicago; Chicago Illinois

2. Health Studies; University of Chicago; Chicago Illinois

3. Committee on Clinical Pharmacology and Pharmacogenomics; University of Chicago; Chicago Illinois

4. Center for Research Informatics; University of Chicago; Chicago Illinois

5. The Computation Institute; University of Chicago; Chicago Illinois

Funder

NIH

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25249/fullpdf

Reference43 articles.

1. Neuroblastoma;Maris;Lancet,2007

2. The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report;Cohn;J Clin Oncol,2009

3. Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project;Moroz;Eur J Cancer,2011

4. Long-term outcomes in survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study;Laverdiere;J Natl Cancer Inst,2009

5. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: Role of treatment;Rubino;Int J Cancer,2003

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory myofibroblastic tumor of the liver after adrenal neuroblastoma surgery: a case report;Discover Oncology;2024-05-18

2. Opaganib Downregulates N-Myc Expression and Suppresses In Vitro and In Vivo Growth of Neuroblastoma Cells;Cancers;2024-05-05

3. Feasibility of ¹⁸F‐DOPA and ¹⁸F‐FDG PET/CT for guiding decision‐making for localized incidental neuroblastoma in infants under 18 months of age;Pediatric Blood & Cancer;2024-04-11

4. Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study;JNCI: Journal of the National Cancer Institute;2024-03-09

5. Local control and toxicity outcomes following consolidative radiation therapy in patients with high-risk neuroblastoma: a 20-year experience at a single center;The Turkish Journal of Pediatrics;2024-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3